Results 161 to 170 of about 29,486 (214)

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age. [PDF]

J Infect Dis
Rostad CA, Campbell JD, Paulsen GC, Ghamloush SS, Xu W, Zheng L, McElrath MJ, De Rosa SC, Girard B, Das R, Anderson EJ, Creech CB.   +11 more
europepmc   +1 more source

POS-975 SEROLOGIC RESPONSE TO THE mRNA-1273 and BNT162b2 COVID-19 VACCINES IN DIALYSIS PATIENTS

, 2022
Kevin Yau, Kento T. Abe, Christopher T. Chan, Anne‐Claude Gingras, Michelle Hladunewich   +4 more
openalex   +1 more source

Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study. [PDF]

Infect Dis Ther
Vicic N, Bogdanov A, Zheng Z, Ryan T, Zeng N, Joshi K, Lu T, Bonafede M, Araujo AB, Wilson A.   +9 more
europepmc   +1 more source

Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera. [PDF]

Front Immunol
Hickey TE, Mudunuri U, Hempel HA, Kemp TJ, Roche NV, Talsania K, Sellers BA, Cherry JM, Pinto LA.   +8 more
europepmc   +1 more source

Immunostimulatory/Immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ivaturi V, Attarwala H, Deng W, Ding B, Schnyder Ghamloush S, Girard B, Iqbal J, Minnikanti S, Zhou H, Miller J, Das R.   +10 more
europepmc   +1 more source

Population-based cohort study assessing the effectiveness of maternal BNT162b2/mRNA-1273 vaccination against infant coronavirus disease 2019 outcomes during Omicron predominance: The VENUS study. [PDF]

Hum Vaccin Immunother
Ishiguro C, Mimura W, Oda F, Maeda M, Fukuda H.   +4 more
europepmc   +1 more source

Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination [PDF]

Salma Younes, Eleonora Nicolai, Massimo Pieri, Sergio Bernardini, Hanin I. Daas, Duaa W. Al‐Sadeq, Nadin Younes, Farah M. Shurrab, Parveen B. Nizamuddin, Fathima Humaira, Nader Al‐Dewik, Hadi M. Yassine, Laith J. Abu‐Raddad, Ahmed Ismail, Gheyath K. Nasrallah   +14 more
openalex   +1 more source

A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers. [PDF]

Front Immunol
Cabrera-Serrano AJ, Ruiz-Durán L, Gutiérrez-Bautista JF, Carretero-Fernández M, Ter Horst R, Li Y, Reyes-Zurita FJ, García-Verdejo FJ, Netea MG, Sánchez-Rovira P, López-Nevot MÁ, Sampedro A, Sainz J.   +12 more
europepmc   +1 more source

mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients. [PDF]

Front Immunol
Girard B, Figueroa AL, De Rosa SC, McElrath MJ, Azzi JR, Stolman D, Siangphoe U, de Windt E, Miller JM, Das R, Priddy F.   +10 more
europepmc   +1 more source

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children. [PDF]

Open Forum Infect Dis
Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC.   +7 more
europepmc   +1 more source